Guangdong T'enkan Pharmaceutical Co., Ltd. 2026 Semi-Annual Report
2026-077
August 18, 2026
Section I Important Tips, Table of Contents, and Definitions
The Board of Directors, directors, and senior management of the Company guarantee that the information in this semi-annual report is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions, and they assume individual and joint legal liability.
Company head Zheng Hanjie, person in charge of accounting work Zhou Guixi, and head of the accounting department (accounting supervisor) Zhou Guixi declare: Guarantee the truth, accuracy, and completeness of the financial report in this semi-annual report.
All directors have attended the board meeting to review this semi-annual report.
Any forward-looking statements in this report, such as future plans or performance forecasts, do not constitute substantive commitments by the Company to investors. Investors and relevant parties should maintain sufficient risk awareness and understand the differences between plans, forecasts, and commitments.
The Company may face risks such as R&D risks, drug marketing risks, agency operation business risks, and goodwill impairment risks. Investors are advised to pay attention to investment risks. Please refer to "Section III Management Discussion and Analysis" under "X. Risks Faced by the Company and Countermeasures."
The Company plans not to distribute cash dividends, not to issue bonus shares, and not to convert capital reserves into share capital.
Table of Contents
Section I Important Tips, Table of Contents, and Definitions 1
Section II Company Profile and Key Financial Indicators 5
Section III Management Discussion and Analysis 8
Section IV Corporate Governance, Environment, and Society 30
Section V Important Matters 34
Section VI Changes in Shares and Shareholder Situation 39
Section VII Bond-Related Information 46
Section VIII Financial Report 47
List of Documents for Inspection
-
Financial statements signed and stamped by the Company's legal representative, the person in charge of accounting work, and the head of the accounting department.
-
Originals of all company documents publicly disclosed during the reporting period.
-
Other relevant documents.
Place for inspection of the above documents: Company Securities Department.